OUTSET MED INC OM
COM · Common Stock · CUSIP 690145107
- SectorHealth care
- IndustryElectromedical & Electrotherapeutic Apparatus
- HeadquartersSan Jose, CA
- FilingsSEC EDGAR
* Summed across managers. Shares that two managers' reports both contain – a subsidiary's holdings that its parent's report includes too, or a sub-adviser's in its client's – are counted once. Holder counts are more reliable. Implied quarter-end price ≈ $19.23.
Trends to Q2 2025
Institutional holders
Managers reporting a position, each quarter
Numbers
| Quarter | Holders |
|---|---|
| Q3 2022 | 139 |
| Q4 2022 | 154 |
| Q1 2023 | 164 |
| Q2 2023 | 156 |
| Q3 2023 | 154 |
| Q4 2023 | 141 |
| Q1 2024 | 115 |
| Q2 2024 | 124 |
| Q3 2024 | 81 |
| Q4 2024 | 75 |
| Q1 2025 | 2 |
| Q2 2025 | 2 |
Buyers vs sellers
Managers adding to or starting a position, vs cutting or selling out
Numbers
| Quarter | Bought or added | Cut or sold out |
|---|---|---|
| Q3 2023 | 74 | 81 |
| Q4 2023 | 69 | 91 |
| Q1 2024 | 46 | 76 |
| Q2 2024 | 64 | 62 |
| Q3 2024 | 21 | 86 |
| Q4 2024 | 24 | 41 |
| Q1 2025 | 0 | 73 |
| Q2 2025 | 2 | 1 |
Calls vs puts
Options held, notional value, last 4 quarters. P/C = puts ÷ calls
Numbers
| Quarter | Calls | Puts | P/C |
|---|---|---|---|
| Q3 2024 | $56.6k | $55.9k | 0.99 |
| Q4 2024 | $158.7k | $72.8k | 0.46 |
| Q1 2025 | $0 | $0 | — |
| Q2 2025 | $0 | $0 | — |
Biggest buyers
| Birchview Capital, LP | Added | +10.0k |
| Accent Capital Management, LLC | New | +150 |
Biggest sellers
| IFP Advisors, Inc | Sold out | -16 |
Major shareholders (over 5%)
Anyone who owns more than 5% of a class of the company's shares has to say so: on Schedule 13D if they may try to influence or control the company, on 13G if they're a passive investor, and update it as the stake changes. Each holder's latest filing, from 19 Dec 2024 on; percentages are of the share class, as the holder worked them out.
| Holder | Stake |
|---|---|
| Durable Capital Partners LP 13G · institution new · filed 2025-01-10 | 9.9% |
| Alyeska Investment Group, L.P. 13G · institution new · filed 2025-05-15 | 9.6% |
| PERCEPTIVE ADVISORS LLC 13G · passive investor new · filed 2025-02-28 | 9.5% |
| FMR LLC 13G · institution filed 2025-02-12 | 7.0% |
Fell to 5% or below in the last year: PFM Health Sciences, LP (2.9%, 2026-02-17)
Insider purchases and sales in Q2 2025
Shares bought or sold by the company's own officers, directors and 10% owners, in the open market or privately, as they reported to the SEC on Form 4 (due within two business days of the trade). Grants, option exercises, shares withheld for tax and gifts aren't included.
Officers and directors buying vs selling
Number of people, by quarter (10% owners not included)
Numbers
| Quarter | Buying | Bought | Selling | Sold | Sold under a plan |
|---|---|---|---|---|---|
| Q3 2023 | 0 | — | 7 | $1.0m | $899.5k |
| Q4 2023 | 0 | — | 7 | $56.4k | — |
| Q1 2024 | 0 | — | 7 | $688.0k | $5.0k |
| Q2 2024 | 0 | — | 6 | $268.5k | $144.1k |
| Q3 2024 | 0 | — | 4 | $2.9k | — |
| Q4 2024 | 0 | — | 4 | — | — |
| Q1 2025 | 0 | — | 4 | — | — |
| Q2 2025 | 0 | — | 4 | $38.6k | — |
| Date | Insider | Trade | Value |
|---|---|---|---|
| 2025-05-15 | Trigg Leslie Chair and CEO, director | Sold | $16.6k935 shares |
| 2025-05-15 | Ahmed Nabeel Chief Financial Officer | Sold | $10.4k584 shares |
| 2025-05-15 | Brottem John L. General Counsel | Sold | $7.1k396 shares |
| 2025-05-15 | Nash Marc SVP Operations and R&D | Sold | $4.5k252 shares |
Their holding: how much the trade added to or took from the insider's holding (direct, or the trust or fund named). The same trade is sometimes reported by more than one insider, such as a fund and the director who represents it; totals count it once. A value is left blank where the reported price is far from the market price (usually a typo).
Holders, Q2 2025
| Manager | Shares | Change |
|---|---|---|
| Birchview Capital, LP 0.66% of their portfolio | 34.6k $664.4k | Added +10.0k |
| Accent Capital Management, LLC 0.00% of their portfolio | 150 $3.6k | New |